Back to TLA

Search Results - pawel+laniewski

2 Results

Sort By:

Diagnostic for Screening and/or Predicting Women "at risk" for the Development and Progression Endometrial Cancer

This invention describes a novel method to use metabolic markers in samples obtained from cervicovaginal lavage (CVL) and machine-learning algorithms to detect patients “at risk” for endometrial cancer (EMC). Background: Endometrial cancer (EMC) is the most common gynecological cancer. The American Cancer Society estimates that in 2021...

Published: 9/7/2022 | Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski

Keywords(s):

Category(s): Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Healthcare Portfolios > Women's Health

Diagnostic for Monitoring Response to Immunotherapies for Gynecologic Cancer

This invention is a collection of immunological checkpoint proteins and physiological markers to diagnose and potentially monitor treatments for cervical cancer. This biomarker panel would be taken using the cervicovaginal lavage method which is a less invasive than other sampling method for cervical cancer. This diagnostic test could be used not only...

Published: 10/16/2019 | Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski

Keywords(s):

Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics